CATALAYER NEWS
Oculis phase 3 trials for diabetic macular edema miss endpoint
Source: Investing.com · 2026-05-29
Full article text is available in the Catalayer news terminal.
MORE FROM INVESTING.COM
Mueller Industries director Scott Jay Goldman sells $255,820 in stock
2026-05-29
Mynd.ai stock surges after regaining NYSE compliance
2026-05-29
TNMP files rate settlement with Texas regulators
2026-05-29
Form 13F Prospect Capital Advisors For: 29 May
2026-05-29
US Space Force awards SpaceX $4.16 billion deal
2026-05-29
RELATED ON CATALAYER
Related Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets